Filing Flows › Orthofix Medical (OFIX) › Q2 FY26 › vs Q2 FY25
Orthofix Medical (OFIX) Q2 FY26 vs Q2 FY25 (year over year)
Orthofix Medical's revenue rose $7.8M (+4%) from $203M in Q2 FY25 to $211M in Q2 FY26. The biggest changes: Global Limb Reconstruction +$4.4M (+13%); Global Spine +$3.4M (+2%).
Orthofix Medical, Q2 FY26: revenue $211M (+4% year over year), operating margin -3.9%, net loss $15.8M, operating cash flow −$6.2M. The chart draws each line against Q2 FY25, the increases inside each band.
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Global Spine | $173M | $170M | $3.4M | +2% |
| Global Limb Reconstruction | $37.7M | $33.3M | $4.4M | +13% |
| Revenue | $211M | $203M | $7.8M | +4% |
| Net loss | $15.8M | $14.1M | $1.7M | +12% |
| Costs & expenses | $227M | $219M | $7.6M | +3% |
| Operating costs | $219M | $219M | −$57K | 0% |
| Interest & other, net | $6.9M | −$1.8M | $8.6M | — |
| Income tax | $801K | −$142K | $943K | — |
| Cost of revenue | $61.2M | $63.6M | −$2.4M | -4% |
| Research & development | $15.9M | $15.9M | $10K | +0.1% |
| SG&A | $138M | $136M | $1.5M | +1% |
| Other operating costs | $3.9M | $3.1M | $758K | +24% |
| Operating cash sources | $27.2M | $13.1M | $14.2M | +109% |
| Depreciation & amortization | $13.3M | $16.9M | −$3.6M | -21% |
| Share-based compensation | $7.7M | $7.8M | −$89K | -1% |
| Cash used in operations | $6.2M | −$11.6M | $17.9M | — |
| Net loss absorbed | $15.8M | $14.1M | $1.7M | +12% |
| Working capital & other | $11.4M | −$1.0M | $12.5M | — |
Questions
How much did Orthofix Medical's revenue grow year over year in Q2 FY26?
Orthofix Medical's revenue rose $7.8M (+4%) from $203M in Q2 FY25 to $211M in Q2 FY26.
What drove Orthofix Medical's revenue change in Q2 FY26?
Global Limb Reconstruction +$4.4M (+13%); Global Spine +$3.4M (+2%).